Device Trial Radar · NCT03195140
Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial
Last checked: Nov 19, 2026Latest source record: Dec 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
103
Actual
Start
Aug 11, 2017
Primary completion
Feb 6, 2018
Study completion Feb 6, 2018
Sponsor
- Lead sponsor
- Tandem Diabetes Care, Inc.Public (TNDM)
- Sponsor type
- Industry
- Collaborators
- Jaeb Center for Health Research
- First posted
- Jun 22, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A 6-week crossover study will compare PLGS to SAP outcomes in adults and youth \> 6 years old with type 1 diabetes (T1D).
Conditions
- Diabetes Mellitus, Type 1
Interventions
Predictive Low Glucose SuspendDevice
Application of Predictive Low Glucose Suspend
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hypoglycemia < 70 mg/dLTime frame: 3 weeks
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
William Sansum Diabetes Center
Santa Barbara, California
Barbara Davis Center
Aurora, Colorado
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.